All updates
All updates
today 43BioPharma Dive精选评分5656 Nature评分3838 Hidden signals in sleep can predict future health
监管与产业动态评分4747 Filling the massive AI drug discovery data gap
Nature评分3939 Keep medical doctors in academia — without them, health-care research will suffer
监管与产业动态评分1111 Signal or noise? > CRISPR Milestone and Gene Therapy Redefine the Curative Landscape of Beta-Thalassemia - Bioengineer.org >> Comment below! #strategy #competitiveintelligence #marketing #competitivemarketing #pharmaceutical #pharma #healthcare #biotech
BioSpace评分3333 Successful CDMO partnerships hinge on honest—and sometimes critical—support
监管与产业动态评分00 Douglas Flora, MD, LSSBB, FACCC - Fierce Biotech
监管与产业动态评分77 Signal or noise? > Endonuclease Enzymes Market To 2035: Gene Editing and Biopharma Demand Drive Expansion - News and Statistics - IndexBox >> Comment below! #strategy #competitiveintelligence #marketing #biotech #pharma #healthcare #pharmaceutical #competitivemarketing
中文产业新闻Chinese source评分2626 11%的美国成年人使用GLP-1减重，约2800万人
The Lancet精选评分5555 [Health Policy] Strengthening health systems to prioritise, provide care, and prevent osteoarthritis: a roadmap for global health policy
The Lancet评分3939 [Editorial] Rethinking threats to human survival
中文产业新闻Chinese source评分2727 NEJM全景综述：乳腺癌系统治疗因靶向、ADC与免疫治疗持续演进
顶刊论文（社媒热度）精选评分4040 Migraine.
顶刊论文（社媒热度）评分3737 Addressing threats to future global health-what is the right timeframe?
中文产业新闻Chinese source评分1717 从国内爆品到全球布局，艾力斯的战役才刚刚开始
NEJM评分3737 Health-Related Social Needs among Older Adults — Addressing Mismeasurement
NEJM评分3131 Firearm-Related Discussions as an Age-Friendly Intervention
NEJM评分3333 Who Counts as Infertile? A Missed Opportunity for Inclusion
监管与产业动态精选评分6363 Physical activity weakens link between genetic risk and depression severity, long-term data suggest
STAT News精选评分6060 Americans trust science more than peers around the world, survey shows
The Lancet评分2828 [Review] Addressing threats to future global health—what is the right timeframe?
The Lancet评分5858 [The Lancet Commissions] The Lancet Commission on 21st century global threats to health
The Lancet评分3636 [Comment] 21st century global threats to health are not what you think
The Lancet评分2727 [Perspectives] John Wong: making an impact on population health at scale
中文产业新闻Chinese source评分3636 2026诺奖之后，医药精细化工的"纯度竞赛"才刚刚开始
文献与产业新闻评分2525 PRMT7 at the crossroads of cancer progression and therapeutic targeting (Review)
监管与产业动态评分2828 4Q26 Public Markets Preview: Pause before the storm?
The Lancet精选评分7171 [Lecture] 50 years of Ebola research and response
监管与产业动态评分2828 cGAS‑STING pathway in digestive tract cancer: From molecular mechanisms to therapeutic applications (Review)
监管与产业动态评分2929 Regulatory T cells in lung adenocarcinoma: Mechanisms of immune escape, prognostic significance and therapeutic opportunities (Review)
监管与产业动态评分1717 Does a bone tumor always mean cancer?
监管与产业动态评分1616 Free lunches for clinicians bloat prescription bills: review - Fierce Pharma
监管与产业动态评分2828 MHRA Chair Professor Anthony Harnden: Bringing our strategy to life – listening, learning, and looking ahead
监管与产业动态评分1111 How we picked the Fierce 15 - Fierce Biotech
监管与产业动态精选评分6565 Tracking molecular malfunctions in metastatic colorectal cancer to find new avenues for treatment
监管与产业动态评分77 How advanced AI can improve clinical trial decision-making - Fierce Pharma
监管与产业动态评分2929 Lipoprotein(a)-dependent cardiovascular risk in different populations: are thresholds the same?
The Lancet Oncology评分3030 [Comment] Time to say goodbye to full-field digital mammography in population-based screening?
监管与产业动态评分2828 Therapeutic Balloon-Assisted Enteroscopy: Recent Advances in the Management of Small Bowel Diseases
监管与产业动态评分2828 PRMT7 at the crossroads of cancer progression and therapeutic targeting (Review)